Unknown

Dataset Information

0

ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.


ABSTRACT: Recent work in human glioblastoma (GBM) has documented recurrent mutations in the histone chaperone protein ATRX. We developed an animal model of ATRX-deficient GBM and showed that loss of ATRX reduces median survival and increases genetic instability. Further, analysis of genome-wide data for human gliomas showed that ATRX mutation is associated with increased mutation rate at the single-nucleotide variant (SNV) level. In mouse tumors, ATRX deficiency impairs nonhomologous end joining and increases sensitivity to DNA-damaging agents that induce double-stranded DNA breaks. We propose that ATRX loss results in a genetically unstable tumor, which is more aggressive when left untreated but is more responsive to double-stranded DNA-damaging agents, resulting in improved overall survival.

SUBMITTER: Koschmann C 

PROVIDER: S-EPMC5381643 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


Recent work in human glioblastoma (GBM) has documented recurrent mutations in the histone chaperone protein ATRX. We developed an animal model of ATRX-deficient GBM and showed that loss of ATRX reduces median survival and increases genetic instability. Further, analysis of genome-wide data for human gliomas showed that ATRX mutation is associated with increased mutation rate at the single-nucleotide variant (SNV) level. In mouse tumors, ATRX deficiency impairs nonhomologous end joining and incre  ...[more]

Similar Datasets

| S-EPMC4513880 | biostudies-literature
| S-EPMC7085449 | biostudies-literature
| S-EPMC3656841 | biostudies-literature
| S-EPMC2848573 | biostudies-literature
| S-EPMC5288581 | biostudies-literature
| S-EPMC7526497 | biostudies-literature
| S-EPMC5937190 | biostudies-literature
| S-EPMC2737594 | biostudies-literature
| S-EPMC7719229 | biostudies-literature
| S-EPMC6252249 | biostudies-literature